AminoAnalytica - About the company
AminoAnalytica is a seed company based in San Francisco (United States), founded in 2024 by Abhi Rajendran, Adam Wu and Matteo Peluso. It operates as a Provider of AI-based platform to optimize enzymes, peptides, and other proteins for pharmaceutical companies. AminoAnalytica has raised $500K in funding from Y Combinator. The company has 79 active competitors, including 42 funded and 5 that have exited. Its top competitors include companies like Nimbus Therapeutics, Generate Biomedicines and Cradle.
Company Details
Provider of AI-based platform to optimize enzymes, peptides, and other proteins for pharmaceutical companies.The platform accelerate the development of novel drugs and therapies by providing a predictive AI platform and physics-based simulations for protein engineering. It improve the properties of target protein sequence from the stability of therapeutic peptides to the activity of industrial enzymes.
- Website
- www.aminoanalytica.com/
- Social
- Email ID
- *****@aminoanalytica.com
Key Metrics
Founded Year
2024
Location
San Francisco, United States
Stage
Seed
Total Funding
$500K in 1 round
Latest Funding Round
Investors
Ranked
45th among 79 active competitors
Employee Count
4 as on May 31, 2026
Similar Companies
Sign up to download AminoAnalytica's company profile
AminoAnalytica's funding and investors
AminoAnalytica has raised a total funding of $500K over 1 round. Its latest funding round was a Seed round on 2024 for $*****. 1 investor participated in its latest round. AminoAnalytica has 1 institutional investor.
Here is the list of recent funding rounds of AminoAnalytica:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2024 | 2455 | Seed | 6772 | 3395 | 5927 | 8310 |
Access funding benchmarks and valuations. Sign up today!View details of AminoAnalytica's funding rounds and investors
AminoAnalytica's founders and board of directors
Founder? Claim ProfileThe founders of AminoAnalytica are Abhi Rajendran, Adam Wu and Matteo Peluso. Abhi Rajendran is the CEO of AminoAnalytica.
Here are the details of AminoAnalytica's key team members:
- Abhi Rajendran: Co-Founder & CEO of AminoAnalytica. Contact Info: 1 email address
- Adam Wu: Co-Founder & CSO of AminoAnalytica. Contact Info: 1 email address
- Matteo Peluso: Co-Founder of AminoAnalytica and founder of 1 other company.
View details of AminoAnalytica's Founder profiles and Board Members
AminoAnalytica's employee count trend
AminoAnalytica has 4 employees as of May 26. Here is AminoAnalytica's employee count trend over the years:
Uncover AminoAnalytica's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AminoAnalytica's Competitors and alternates
Top competitors of AminoAnalytica include Nimbus Therapeutics, Generate Biomedicines and Cradle. Here is the list of Top 10 competitors of AminoAnalytica, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Nimbus Therapeutics 2009, Cambridge (United States), Series F | Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 68/100 | |
2nd |  Generate Biomedicines 2018, Somerville (United States), Public | Developer of a platform for generating novel protein-based therapeutic modalities | $693M | 66/100 | |
3rd |  Cradle 2021, Zurich (Switzerland), Series B | Provider of chemoproteomics solutions for protein design and development | $103M | 64/100 | |
4th |  EvolutionaryScale 2023, New York City (United States), Seed | Provider of an AI models for protein design | $142M | 64/100 | |
5th |  Profluent Bio 2022, Berkeley (United States), Series B | Provider of an artificial intelligence-based protein design platform | $150M | 64/100 | |
6th | Frontier Medicines 2018, San Francisco (United States), Series C | Developer of a bioinformatics platform for drug development and chemoproteomics | $236M | 64/100 | |
7th |  Eikon 2019, Millbrae (United States), Public | Protein tracking and measuring tool for drug discovery | $1.16B | 62/100 | |
8th |  Seismic 2019, Watertown (United States), Series B | AI-assisted platform for drug discovery and development | $247M | 61/100 | |
9th |  Vividion Therapeutics 2016, Oceanside (United States), Acquired | Pioneering chemoproteomics and covalent chemistry for precision therapeutics targeting undruggable disease drivers | $271M | 61/100 | |
10th | Orbit Discovery 2015, Oxford (United Kingdom), Series A | Developer of a drug discovery platforms by peptide display engine | $15.7M | 59/100 | |
45th | AminoAnalytica 2024, San Francisco (United States), Seed | Provider of AI-based platform to optimize enzymes, peptides, and other proteins for pharmaceutical companies | $500K | 30/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on AminoAnalytica's competitors? Click here to see the top ones
AminoAnalytica's Investments and acquisitions
AminoAnalytica has made no investments or acquisitions yet.
Reports related to AminoAnalytica
Here is the latest report on AminoAnalytica's geography:
Are you a Founder ?
FAQs about AminoAnalytica
Explore our recently published companies
- Uclaubsbruins - 1981 founded, Unfunded company
- Realtyconsultants - Unfunded company
- Trade Links - Delhi based, 1951 founded, Unfunded company
- SpeedCalcs - Kingston based, 2025 founded, Unfunded company
- Himalaya Wellness Company - Bengaluru based, 1930 founded, Unfunded company
- Jindal Renewables - Gurugram based, 2023 founded, Unfunded company
